DA
Derek Archila Wells Fargo Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
26
Kyverna Therapeutics
KYTX
$169M
| $4.10 | $24 |
485%
upside
| Overweight |
15 Nov ‘24
9 months ago |
|
27
Ventyx Biosciences
VTYX
$170M
| $2.38 | $11 |
362%
upside
| Overweight |
12 Aug ‘24
1 year ago |
|
28
Annexon
ANNX
$243M
| $2.12 | $10 |
372%
upside
| Overweight |
15 May ‘24
1 year ago |
|
29
Immunovant
IMVT
$2.85B
| $16.40 | $9 |
45%
downside
| Hold |
1 Jun ‘21
4 years ago |
|
30
Esperion Therapeutics
ESPR
$506M
| $2.54 | $20 |
687%
upside
| Hold |
5 May ‘21
4 years ago |
|
31
Apellis Pharmaceuticals
APLS
$3.4B
| $26.84 | $40 |
49%
upside
| Buy |
1 Sep ‘20
5 years ago |
|
|
IVA
32
Inventiva
IVA
$747M
| $5.36 | $18 |
236%
upside
| Buy |
4 Aug ‘20
5 years ago |
|
33
Galapagos
GLPG
$2.21B
| $32.67 | $193 |
491%
upside
| Hold |
10 Jul ‘20
5 years ago |
|
34
Oneok
OKE
$44.9B
| $71.84 | $41 |
43%
downside
| Buy |
15 Apr ‘20
5 years ago |
|
|
AMRN
35
Amarin Corp
AMRN
$306M
| $15.22 | $160 |
951%
upside
| Hold |
31 Mar ‘20
5 years ago |
|
|
DBVT
36
DBV Technologies
DBVT
$238M
| $9.40 | $60 |
538%
upside
| Hold |
17 Mar ‘20
5 years ago |
|